Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DaRT Treated Patients”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableStudy completedNCT05125354
What this trial is testing

A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT

Who this might be right for
Squamous Cell CarcinomaDaRT Treated Patients
Alpha Tau Medical LTD. 33
Not applicableLooking for participantsNCT06202118
What this trial is testing

Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

Who this might be right for
Breast CancerRecurrent Breast CancerBreast Carcinoma
Alpha Tau Medical LTD. 10
Not applicableActive Not RecruitingNCT05323253
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma

Who this might be right for
Recurrent Squamous Cell Carcinoma
Alpha Tau Medical LTD. 86
Not applicableStudy completedNCT00116415
What this trial is testing

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Who this might be right for
HIV InfectionsAIDS
Bristol-Myers Squibb 65
Not applicableLooking for participantsNCT06615635
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Who this might be right for
Squamous Cell CarcinomaAlpha RadiationImmunocompromised+3 more
Alpha Tau Medical LTD. 28
Testing effectiveness (Phase 2)Looking for participantsNCT06940297
What this trial is testing

Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Mayo Clinic 44
Not applicableUnknownNCT01985269
What this trial is testing

Modified Directly Observed Antiretroviral Therapy

Who this might be right for
HIV
Moi University 511
Not applicableStudy completedNCT05012865
What this trial is testing

Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)

Who this might be right for
Renal Cell Carcinoma
Pfizer 48
Post-approval studies (Phase 4)Study completedNCT00116116
What this trial is testing

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Who this might be right for
HIV InfectionsAIDS
Bristol-Myers Squibb 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798